Mycenax Biotech (4726) — Free Cash Flow Generation Index

Latest as of March 2025: -4.90x

Mycenax Biotech (4726) has a Free Cash Flow Generation Index of -4.90x as of March 2025. Free cash flow of NT$-70.01 Million represents -5% of operating cash flow (NT$14.29 Million). See working capital to net assets of Mycenax Biotech to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

-4.90x

Free Cash Flow / Operating CF

Free Cash Flow

NT$-70.01 Million

TWD

Operating Cash Flow

NT$14.29 Million

TWD

Capital Expenditures

NT$84.30 Million

TWD

Mycenax Biotech Free Cash Flow Generation Index (2020–2020)

Historical FCF Generation Index trend for Mycenax Biotech across 1 annual periods. Explore cash flow to debt ratio of Mycenax Biotech to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Mycenax Biotech (2020–2020)

Year-by-year Free Cash Flow Generation Index for Mycenax Biotech. For the full company profile including market capitalisation, see Mycenax Biotech (4726) market capitalisation.

Year	FCG Index	Free Cash Flow (TWD)	Operating CF	Capital Expenditures	YoY Change
2020	-0.51x	NT$-88.09 Million	NT$174.17 Million	NT$260.22 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).